This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

End of study analyses of the phase III trials of prophylactic human papillomavirus (HPV)
virus-like particle (VLP) vaccines in young women are now largely completed. Two distinct …

Human papilloma virus (HPV) is the most common sexually transmitted infection worldwide
causing a variety of benign and malignant conditions. A significant portion of the global …

Immunization is the most successful method in preventing and controlling infectious
diseases, which has helped saving millions of lives worldwide. The discovery of the human …

Abstract The Human Papillomavirus Prevention and Control Board brought together experts
to discuss optimizing HPV vaccination and screening programs. Board members reviewed …

Vaccination against human papillomavirus (HPV) promises to dramatically decrease the
incidence of HPV-related diseases, including cervical cancer. Although this vaccine is …

Human papillomavirus (HPV) is the most common sexually transmitted infection in the
United States, and persistent HPV infection is strongly associated with risk of cervical cancer …

This article presents the World Health Organization's (WHO) recommendations on the use of
human papillomavirus (HPV) vaccines excerpted from the WHO position paper on Human …

Vaccination to prevent human papillomavirus infections: From promise to practice | PLOS
Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue Journal …

Background HPV is a common sexually transmitted infection, with HPV acquisition generally
occurring soon after first sexual activity (1). Most HPV infections are transient and …